| Effect of Metformin in Patients With Type-1 Diabetes With Inadequate Glycaemic Control by Insulin and Diet (NCT00118937) | Steno Diabetes Center Copenhagen | 2003-12-01 |
| Paediatric Subjects - Special Survey (NCT01538576) | Novo Nordisk A/S | 2003-12-01 |
| Allogenic Islet Cell Transplantation (NCT00160732) | University of Chicago | 2003-10-01 |
| Effect of C-Peptide on Diabetic Peripheral Neuropathy (NCT00278980) | Creative Peptides Sweden Inc. | 2003-10-01 |
| Efficacy and Safety of Insulin Aspart in MDI or CSII in Children Below 7 Years of Age With Type 1 Diabetes (NCT00571935) | Novo Nordisk A/S | 2003-08-01 |
| Islet Transplantation for Patients With Type 1 Diabetes (NCT00073281) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2003-08-01 |
| Comparison of Two Pen Systems in Patients With Diabetes Treated With Insulin (NCT00569998) | Novo Nordisk A/S | 2003-08-01 |
| Islet Cell Transplants for Diabetes (NCT00303134) | Weill Medical College of Cornell University | 2003-08-01 |
| Efficacy and Safety of Biphasic Insulin Aspart 30 in Type 1 or 2 Diabetes (NCT00617565) | Novo Nordisk A/S | 2003-07-08 |
| Comparison of Insulin Aspart Produced by the NN2000 Process to the Current Process in Type 1 Diabetes (NCT00604656) | Novo Nordisk A/S | 2003-05-05 |
| Comparison of Human Insulin Produced by the Current Process and the NN729 Process in Type 1 Diabetes (NCT00569400) | Novo Nordisk A/S | 2003-05-01 |
| Efficacy and the Safety of Insulin Detemir in Subjects With Insulin Requiring Diabetes (NCT00604344) | Novo Nordisk A/S | 2003-04-01 |
| Safety and Efficacy of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes Mellitus. (NCT00063128) | Eli Lilly and Company | 2003-04-01 |
| Matrix Metalloproteinases and Diabetic Nephropathy (NCT00067886) | Arkansas Children's Hospital Research Institute | 2003-03-01 |
| NovoLet® Surveillance Study on Using Human Insulin System in Indonesia (NCT01492153) | Novo Nordisk A/S | 2003-02-11 |
| Comparison of Glycemic Control Achieved With 2 Different Needles (NCT00572052) | Novo Nordisk A/S | 2002-12-01 |
| Comparison of Human Insulin to Insulin Inhalation Solution in Children With Type 1 Diabetes (NCT00567775) | Novo Nordisk A/S | 2002-10-21 |
| Human Insulin NPH and Insulin Aspart in Type 1 Diabetes (NCT00597233) | Novo Nordisk A/S | 2002-10-01 |
| Long Term Safety Trial to Compare Insulin Treatment With Preprandial Inhaled Human Insulin to s.c. Insulin Aspart Both Combined With NPH in Subjects With Type 1 Diabetes (NCT00725036) | Novo Nordisk A/S | 2002-09-02 |
| Efficacy and Safety of Insulin Aspart vs. Human Insulin During Pregnancy by Women With Type 1 Diabetes (NCT00365170) | Novo Nordisk A/S | 2002-09-01 |
| Pharmacokinetics of Insulin Detemir in Subjects With Type 1 Diabetes (NCT01542450) | Novo Nordisk A/S | 2002-08-01 |
| Comparison of Efficacy and Safety of Insulin Detemir and NPH Insulin in Children and Adolescents With Type 1 Diabetes (NCT00312156) | Novo Nordisk A/S | 2002-08-01 |
| Islet Transplantation in Type 1 Diabetics Using the Edmonton Protocol of Steroid Free Immunosuppression (NCT00133809) | Emory University | 2002-07-01 |
| Safety and Efficacy of Insulin Aspart in Children With Type 1 Diabetes (NCT01467141) | Novo Nordisk A/S | 2002-06-19 |
| Evaluation of the Bioavailability of Pramlintide (NCT00042471) | AstraZeneca | 2002-06-01 |
| Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population (NCT00071448) | Novo Nordisk A/S | 2002-06-01 |
| TRIGR - Primary Prevention Study for Type 1 Diabetes in Children at Risk (NCT00179777) | University of Helsinki | 2002-05-06 |
| Efficacy and Safety of Inhaled Insulin Compared With Subcutaneous Human Insulin Therapy in Adults With Type 1 Diabetes (NCT00137046) | Pfizer | 2002-05-01 |
| Treatment With hOKT3gamma1(Ala-Ala) in T1DM (NCT00806572) | National Institute of Allergy and Infectious Diseases (NIAID) | 2002-05-01 |
| Special Survey for Type 1 or Type 2 Diabetic Patients (NCT01487408) | Novo Nordisk A/S | 2002-04-01 |
| Special Survey for Paediatric Subjects (NCT01487382) | Novo Nordisk A/S | 2002-04-01 |
| Insulin Glargine in Type I Diabetes Mellitus> Main Study "AT.LANTUS": A Trial Comparing Lantus Algorithms to Achieve Normal Blood Glucose Targets in Subjects With Uncontrolled Blood Sugar. Sub-study: "HALT"(Hypoglycaemia Avoidance With Lantus Trial) (NCT00390728) | Sanofi | 2002-04-01 |
| Evaluation of Dose-titration of Pramlintide During Initiation of Therapy in Patients Trying to Improve Glucose Control (NCT00042458) | AstraZeneca | 2002-04-01 |
| Comparison of Efficacy and Safety of Insulin Detemir and Insulin Glargine in Patients With Type 1 Diabetes (NCT00312104) | Novo Nordisk A/S | 2002-04-01 |
| Special Survey of Production of Insulin Aspart Specific Antibody (NCT01487369) | Novo Nordisk A/S | 2002-04-01 |
| Flexible, Intensive Insulin Therapy in Patients With Type 1 Diabetes (NCT00595569) | University of Lausanne Hospitals | 2002-04-01 |
| Long Term Safety of Biphasic Insulin Aspart 30 in Juveniles With Type 1 Diabetes (NCT01486381) | Novo Nordisk A/S | 2002-03-20 |
| Comparison of Insulin Detemir Plus Insulin Aspart With Insulin NPH Plus Human Soluble Insulin in Subjects With Type 1 Diabetes (NCT01486940) | Novo Nordisk A/S | 2002-03-01 |
| European Trial of Immunosuppression in SPK Tx (NCT00140543) | EUROSPK Study Group | 2002-02-01 |
| Comparison Between Insulin Pump Treatment and Multiple Daily Insulin Injections in Diabetic Type 1 Children (NCT00462371) | Erasmus Medical Center | 2002-01-01 |
| Single Dose and 34-Day Tolerance Study of INGAP Peptide in Insulin Deficient Patients (NCT00034255) | GMP Endotherapeutics | 2001-12-01 |
| Noninvasive Transcutaneous Glucometer Development (NCT01168076) | InLight Solutions | 2001-12-01 |
| Glulisine Pre- and Postmeal (NCT00290043) | Sanofi | 2001-12-01 |
| SAM - Skip a Meal - Insulin Glargine, Diabetes Mellitus Type 1 (NCT00313937) | Sanofi | 2001-11-01 |
| 32 Week, Open, Randomized, 2 Way Cross Over Multicentre Trial to Compare Safety & Efficacy of Combination of HOE901 Insulin Analogue Once Daily at Bedtime + Lispro Insulin Before Meals vs NPH Insulin (Twice a Day) + Regular in Type 1 Diabetes Mellitus (NCT00537251) | Sanofi | 2001-11-01 |
| Pre Transplant Rapamycin Treatment in Islet Transplantation Alone (NCT01060605) | IRCCS San Raffaele | 2001-10-01 |
| Frequency of Hypoglycaemic Episodes During Treatment With Insulin Detemir in Well Controlled Subjects With Type 1 Diabetes (NCT01697657) | Novo Nordisk A/S | 2001-09-01 |
| Genetics Of Autoimmunity In Type I Diabetes (NCT03648918) | Medical College of Wisconsin | 2001-08-01 |
| Comparison of Single Dose and Steady State Pharmacodynamics of Biphasic Insulin Aspart 30 and 70 in Subjects With Type 1 Diabetes (NCT01526941) | Novo Nordisk A/S | 2001-05-01 |
| Evaluation of the Efficacy and Safety of Insulin Detemir Compared With That of NPH Insulin in Subjects With Type 1 Diabetes. (NCT03220425) | Novo Nordisk A/S | 2001-02-01 |
| Pharmacokinetics of Biphasic Insulin Aspart 30 and 70 in Subjects With Type 1 Diabetes (NCT01524809) | Novo Nordisk A/S | 2001-01-01 |
| Islet Cell Transplantation in Patients With Type I Diabetes With Previous Kidney Transplantation (NCT00315588) | Rodolfo Alejandro | 2000-12-01 |
| Solitary Islet Transplantation for Type 1 Diabetes Mellitus Using Steroid Sparing Immunosuppression (NCT00006505) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2000-11-16 |
| Polyclonal Anti-T-Lymphocyte Globulin (ATG) in Type 1 Diabetes (NCT00190502) | Institute for Clinical and Experimental Medicine | 2000-11-01 |
| Beta-Cell Transplantation in Pre-Uremic Patients With Type 1 Diabetes (NCT00623610) | Universitair Ziekenhuis Brussel | 2000-09-01 |
| Islet Cell Transplantation Alone in Patients With Type I Diabetes Mellitus: Steroid-free Immunosuppression (NCT00021788) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2000-07-01 |
| Extension of Phase II Therapeutic Trial With a Humanized Non-Mitogenic CD3 (ChAgly CD3) Monoclonal Antibody in Recently Diagnosed Type 1 Diabetic Patients (NCT00627146) | Universitair Ziekenhuis Brussel | 2000-06-01 |
| Comparison of Biphasic Human Insulin 30 With Biphasic Insulin Aspart in Subjects With Diabetes (NCT01520818) | Novo Nordisk A/S | 2000-03-01 |
| Examining the Long-term Safety of Insulin Aspart When Used as a Part of the Treatment for Type 1 Diabetes (NCT00832182) | Novo Nordisk A/S | 1999-12-22 |
| Six Month Clinical Trial Assessing Efficacy And Safety Of Inhaled Insulin In Type 1 Diabetes Mellitus. (NCT00424437) | Pfizer | 1999-09-01 |
| Six Month Clinical Trial Assessing Efficacy and Safety of Inhaled Insulin in Type 1 Diabetes (NCT00424333) | Pfizer | 1999-05-01 |
| The Relationship Between Stage of Diabetic Retinopathy and Retinal Blood Flow in Patients With IDDM During Euglycemic Clamp (NCT00814008) | Medical University of Vienna | 1999-03-01 |
| Efficacy and Safety of Biphasic Insulin Aspart 30 in Type 1 or Type 2 Diabetes (NCT01467323) | Novo Nordisk A/S | 1998-04-01 |
| Comparison of 2 NovoFine® Needles on the Reflux of Insulin (NCT00872560) | Novo Nordisk A/S | 1998-01-20 |
| Safety and Efficacy of Insulin Aspart in Subjects With Type 1 Diabetes (NCT01707134) | Novo Nordisk A/S | 1997-09-01 |
| Localisation of Potential Insulin Deposits in Normal Weight and Obese Diabetics Using 6 mm and 12 mm Long Needles (NCT00871416) | Novo Nordisk A/S | 1997-04-09 |
| A Study of Two Versus Three Daily Injections in Children and Adolescents With Newly Diagnosed Type 1 Diabetes (NCT00146484) | Children's Hospital of Eastern Ontario | 1996-04-01 |
| Comparison of Antibody Levels in Children and Adolescents After Initiation of Insulin Therapy by Either Insulin Aspart or Soluble Human Insulin (NCT00410033) | Novo Nordisk A/S | 1989-12-01 |
| Ingested Interferon Alpha: Prolongation or Permanence of the "Honeymoon" Phase in Newly Diagnosed Type 1 Diabetes Mellitus (NCT00005665) | National Center for Research Resources (NCRR) | |
| Efficacy of Calcitriol in Recent Onset Type 1 Diabetes (NCT01120119) | Campus Bio-Medico University | |
| Immunosuppressive Medications for Participants in ITN005CT (NCT00014911) (NCT01309022) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Pre-Approval Access to Golimumab Subcutaneous for the Treatment of Stage 3 Type-1 Diabetes Mellitus in Children and Young Adults (NCT03945903) | Janssen Research & Development, LLC | |